MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-06-2026
IRadimed Corporation Cash and Cash Equivalents 2011-2026 | IRMD
Annual Cash and Cash Equivalents IRadimed Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.2 M | 52.2 M | 49.8 M | 58 M | 62 M | 50.1 M | 43.5 M | 28 M | 18.2 M | 17.7 M | 19.4 M | 9.45 M | 2.46 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62 M | 2.46 M | 35.5 M |
Quarterly Cash and Cash Equivalents IRadimed Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.5 M | 53 M | 50.3 M | 52.2 M | 51.7 M | 48.5 M | 45.1 M | 49.8 M | 46.7 M | 45.8 M | 42.8 M | 58 M | 55.6 M | 52.2 M | 50.4 M | 62 M | 58.4 M | 55.2 M | 50.8 M | 50.1 M | 50.1 M | 50.1 M | 50.1 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 28 M | 28 M | 28 M | 28 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 9.45 M | 9.45 M | 9.45 M | 9.45 M | 2.46 M | 2.46 M | 2.46 M | - | 1.7 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62 M | 1.7 M | 34.1 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B |  USA |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 9.38 | -1.83 % | $ 722 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.08 | -1.3 % | $ 325 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
4.14 M | $ 2.43 | -5.02 % | $ 6.74 M | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
Outset Medical
OM
|
35 M | $ 3.48 | -1.56 % | $ 52.9 K | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 36.39 | -1.73 % | $ 1.13 B | USA |
 |
Sensus Healthcare
SRTS
|
22.1 M | $ 4.05 | -4.03 % | $ 66.1 M | USA |
 |
Electromed
ELMD
|
15.3 M | $ 24.53 | -0.53 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Stryker Corporation
SYK
|
4.01 B | $ 331.46 | 1.19 % | $ 127 B | USA |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.61 | -9.13 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.33 | 0.43 % | $ 3.64 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
636 M | $ 63.53 | 0.36 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
8.94 M | $ 1.76 | 0.29 % | $ 113 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 11.34 | -0.44 % | $ 1.53 B | USA |
 |
Penumbra
PEN
|
187 M | $ 336.4 | 0.04 % | $ 13.1 B | USA |
 |
Tandem Diabetes Care
TNDM
|
90.6 M | $ 23.43 | -3.44 % | $ 1.59 B | USA |
 |
MiMedx Group
MDXG
|
166 M | $ 3.94 | -4.02 % | $ 582 M | USA |
 |
TELA Bio
TELA
|
50.8 M | $ 0.75 | 7.97 % | $ 35.2 M | USA |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
14.1 M | $ 0.68 | -2.24 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
752 K | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
105 M | $ 50.39 | -1.98 % | $ 1.48 B | USA |
 |
Viemed Healthcare
VMD
|
13.5 M | $ 9.25 | -1.11 % | $ 360 M | USA |
 |
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.26 | -2.69 % | $ 51.3 M | USA |
 |
Varex Imaging Corporation
VREX
|
145 M | $ 10.71 | 0.19 % | $ 443 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | USA |